Meghan Monaghan

Our Website Uses Cookies

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

PDF Binder
- Create PDF
- Add to Binder
Word Document Binder

Meghan Monaghan

Associate

Washington +1 202 662 5531 mmonaghan@cov.com Download V-card

View Less

Meghan Monaghan is a litigator who focuses on patent litigation. She represents a variety of clients in patent litigation matters, with a concentration on the pharmaceuticals industry.

Representation of a pioneer pharmaceutical company in multiple patent litigation suits brought in the District of South Carolina involving a statin drug product.
Representation of a major pharmaceutical company in Hatch-Waxman litigation against several generic drug manufacturers relating to injectable drug used to treat diabetes.
Representation of a small biopharmaceutical company in Hatch-Waxman litigation involving combination therapy designed to maintain pupil size during cataract surgery or intraocular lens replacement and reduce postoperative ocular pain.
Representation of a major pharmaceutical company in Hatch-Waxman litigation related to fertility drugs.

FDA Advertising and Promotion Enforcement Activities in March 2014

The Office of Compliance (OC) in the FDA’s Center for Devices and Radiological Health issued a warning letter to NeoMedix Corporation regarding the Trabectome High Frequency Generator/LP (Trabectome) on February 26, 2014. The warning letter included allegations that Neomedix’s website made claims about Trabectome that represented a “major change or modification” ...

View More View Less

Our Website Uses Cookies

Representative Matters

News and Insights (Showing 5 of 6) (Showing 6 of 6)

Summary of FDA Advertising and Promotion Enforcement Activities

Summary of FDA Advertising and Promotion Enforcement Activities

Summary of FDA Advertising and Promotion Enforcement Activities - May 2014

FDA Advertising and Promotion Enforcement Activities in March 2014

Summary of FDA Advertising and Promotion Enforcement Activities - March 2014

CMS Issues Final Rule to Implement the Sunshine Act

Practices

Education

Washington and Lee University School of Law, J.D., 2011

Bucknell University, B.A., 2008

Judicial Clerkship

Bar Admissions